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Abstract 
Objective: The present study aimed to examine whether Anorexia Nervosa (AN) 
illness severity or duration is associated with retention or treatment response in outpatient, 
enhanced cognitive behavioural therapy (CBT-E).  Method: Patients with a confirmed AN 
diagnosis (N = 134) completed measures of eating disorder symptoms and quality of life, and 
had their BMI objectively measured before, during, and after treatment.  We evaluated 
whether illness severity or duration predicted treatment outcomes, using longitudinal 
regression models.  Results: Greater levels of illness severity and duration were not 
associated with poorer treatment outcomes.  Conclusions: Patients with more severe or long-
standing AN illness did just as well in CBT-E as any other patient starting treatment.  
Therefore, classifying individualVDVµVHYHUHDQGHQGXULQJ¶appears to lack clinical utility in 
CBT-E.  Clinicians should continue to administer evidence-supported treatments such as 
CBT-E for patients with AN, regardless of duration or severity of AN illness. 
 
Public Health Statement: "This study strongly suggests that outpatient CBT-E is an equally 
acceptable and effective treatment for adults with anorexia nervosa, regardless of duration or 
severity´  
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Severe and enduring anorexia nervosa?  Illness severity and duration are unrelated to 
outcomes from enhanced cognitive behaviour therapy 
The WHUPµsevere and enduring anorexia nervosa¶ (SE-AN) is prevalent in clinical and 
research settings as a descriptor for a subgroup of individuals with AN.  SE-AN is typically 
designated based on illness duration, yet there is no consensus regarding the length of illness 
that makes up SE-AN (Wildes et al., 2017; Wonderlich et al., 2012). Diverse definitions have 
been applied, such as at least three years (Hay, Touyz, & Sud, 2012), at least 7 years (Calugi 
et al., 2016; Touyz et al., 2013), and at least 10 years (Arkell & Robinson, 2008).   
Illness duration is associated with poorer prognosis for patients with AN across 
different treatment settings and modalities (Keel & Brown, 2010).  However, there is little 
evidence regarding the impact of illness duration on specific therapies, such as enhanced 
cognitive behavioural therapy (CBT-E; Fairburn, 2008).  A single study (Calugi et al., 2016) 
found that patients with or without SE-AN (defined as duration of at least 7 years) did not 
differ significantly on treatment outcomes following inpatient CBT-E.  Groups had similar 
improvements in BMI, eating disorder symptoms, and general psychopathology at post-
treatment and 12-month follow-up.  These findings question the clinical utility of the µVHYHUH
DQGHQGXULQJ¶ AN construct in CBT-E. 
The word µVHYHUH¶ is embedded in the term SE-AN, yet AN severity is rarely used to 
classify an individual as SE-AN.  The Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5; American Psychiatric Association, 2013) classifies AN severity based on BMI 
bands.  However, patients with AN categorised as mild (>=17.0 BMI), moderate (16-16.99 
BMI), severe (15-15.99 BMI), and extreme (<15 BMI) are indistinguishable on age, clinical 
impairment, or eating disorder symptoms (e.g., Reas & Ro, 2017).  Thus, DSM-5 severity 
may lack clinical utility at pre-treatment.  However, BMI is also not the only variable that 
could be used to define severity, as the severity of pre-treatment eating disorder attitudes and 
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cognitions could be used instead.  Further research is needed to assess whether BMI or eating 
disorder symptom severity predict retention or outcome in CBT-E for AN.   
Wildes et al. (2017) used structural equation modelling to investigate the validity of 
the µVHYHUHDQGHQGXULQJ¶AN construct, concluding that it lacked validity.  They criticised 
the common practice of dichotomising illness severity into categories (e.g., less than or 
greater than 7 years), arguing that illness duration and severity are dimensions that should be 
conceptualised as such by researchers and clinicians. While the clinical utility of SE-AN 
classification has not been established, guidelines have emerged that encourage clinicians to 
de-emphasise goals of renourishment and weight restoration for SE-AN, and instead focus on 
harm minimisation and quality of life (Hay et al., 2014; Strober, 2004; Touyz et al., 2013).  
Rehabilitation over recovery has been recommended, following staging models for psychotic 
illness (e.g., Arkell & Robinson, 2008).  By contrast, goals of weight restoration and 
renourishment are at the forefront of evidence-supported interventions, such as family-based 
treatment (Lock & le Grange, 2015) and CBT (Fairburn, 2008) for other individuals with AN.  
Recommending different treatment of SE-AN may be premature, given that there is 
QRDFFHSWHGGHILQLWLRQRIµVHYHUHDQGHQGXULQJ¶$1QRUHYLGHQFHWKDWduration or severity of 
AN is associated with poorer outcomes in existing evidence-supported treatments.  The 
present study aimed to evaluate whether the severity or duration of AN affect treatment 
retention or outcome in outpatient CBT-E.   
Method 
Participants 
 Participants were 134 consecutive patients who entered CBT-E at a public mental 
health service with a dedicated outpatient eating disorders service.  All patients met DSM-5 
criteria for AN (APA, 2013).  Exclusion criteria were current psychosis, significant alcohol or 
substance abuse/dependence, or medical instability.  Sample characteristics are presented in 
Running head: ANOREXIA SEVERITY AND DURATION IN CBT-E                          5 
 
Table 1. The study received approval from the ,QVWLWXWLRQ¶V+XPDQ5HVHDUFK(WKLFV
Committee (Approval Number QI 2014/39). 
Procedure and Measures 
Patients were assessed and treated by Clinical Psychologists experienced in the 
treatment of eating disorders.  The Eating Disorder Examination interview (EDE Version 12; 
Fairburn & Cooper, 1993) was administered at assessment to determine eating disorder 
diagnosis.  CBT-E was then administered individually (see Byrne et al., 2011 for details of 
training and implementation).  CBT-E is a manual-based treatment (Fairburn, 2008) that has 
demonstrated efficacy (Fairburn et al., 2009).   
Patients were weighed (clothed but without shoes or outer garments) at assessment 
and every treatment session to calculate objective BMI.  Severity of eating disorder attitudes 
and behaviours was measured using the clinician-rated EDE global score at pre-WUHDWPHQWĮ
= .91), and the self-report Eating Disorder Examination Questionnaire global score (EDE-Q; 
Fairburn & Beglin, 1994; Į DWSUH-treatment, post-treatment, and five weekly intervals 
throughout treatment. The first 87 patients in the sample also completed the Quality of Life 
and Enjoyment Satisfaction Questionnaire-Short Form (QLESQ; Endicott et al., 1993Į 
.91) (after this, the service discontinued use of this measure).  Treatment completion was 
defined as successful transition through all stages of CBT-E, with mutual termination of 
treatment by therapist and patient after the final stage.  Illness duration was assessed using a 
self-report questionnaire that asked respondents for detailed information pertaining to the age 
of onset of key eating disorder cognitions and behaviours, as well as a detailed weight 
history.  Self-report data were used to guide clinical interview to determine the duration (in 
months) for which the individual presented with uninterrupted symptoms of AN. 
Data Analysis 
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We evaluated whether the duration or severity of AN predicted treatment outcomes.  
The predictor variables were (a) illness duration, (b) pre-treatment EDE score, and (c) pre-
treatment BMI.  The outcome variables were (a) treatment completion, (b) change in eating 
disorder attitudes and cognitions (EDE-Q), (c) change in quality of life (QLESQ), (d) change 
in BMI over the first five treatment sessions (an indicator of rapid response), and (e) change 
in BMI over 40 treatment sessions (standard length of CBT-E).  Separate analyses were 
conducted for each predictor and outcome.  We used nonparametric and logistic regression to 
evaluate associations between each predictor and treatment completion.  For other outcomes, 
we used longitudinal regression modelling1 to test whether there was an interaction between 
the predictors and time (i.e., did the trajectory of the outcome variable depend on illness 
duration or severity?).  Analyses were conducted using R 3.4.4 (www.R-project.org).  
Results 
We summarise the salient findings here.  The results of all analyses, along with data 
and code that can be used to replicate or extend our analyses, are available on the Open 
Science Foundation (URL: masked for anonymous review). 
Treatment Characteristics 
 Sixty-nine (51.5%) participants were classified as treatment completers.  They 
attended a mean of 38.4 (SD = 21.4) sessions. Non-completers attended a mean of 12.2 (SD = 
10.2) sessions. Both groups demonstrated significant improvements on EDE-Q and BMI 
from pre- to post-treatment.  Reasons for non-completion ranged from missing scheduled 
sessions (and not responding to attempts to make contact) through to being unable to continue 
due to gaining employment or moving away.  There were no significant differences between 
completers and non-completers on pre-treatment variables, except for a small difference in 
baseline EDE-Q scores (Completers M = 4.14 (SD 1.30), Non-Completers 3.66 (SD = 1.38), 
Difference = 0.49, 95% CI [.02, .95], d = .36, p = .040.] 
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Predictor 1: Illness Duration 
 There was a small association between illness duration and the probability of 
completing treatment (p = .039, pseudo-R2 = .10), however the association was curvilinear 
(U-shaped, top panel, Figure 1).  For example, a patient with illness duration of two years had 
the same likelihood of completing treatment (64%) as a patient with illness duration of 18 
years.  Illness duration did not predict changes in eating disorder symptoms, quality of life, or 
BMI (see bottom panel, Figure 1).  Predicted trajectories of change in eating disorder 
symptoms for patients with 3, 7 and 11 year illness durations are plotted.  If illness duration 
was associated with poorer outcome, the slope of the trajectory for patients with an 11-year 
illness duration would be flatter (indicating less improvement) than the slope for patients with 
a 7-year duration, who in turn would have a flatter slope than patients with a 3-year duration.  
However, the trajectories are parallel, indicating that illness duration has no impact on change 
in eating disorder symptoms (interaction between illness duration and time - p = .93).  Similar 
patterns emerged when we plotted trajectories for the other outcomes variables. 
Predictor 2: Pre-treatment Eating Disorder Symptom Severity 
 Pre-treatment EDE scores did not predict outcome on any of the five dependent 
variables.  Predicted trajectories of change in BMI over the first five sessions of treatment 
have been plotted for participants with pre-treatment EDE scores of 3.04, 3.97 and 4.66 
(corresponding to the 25th, 50th, and 75th percentiles of the distribution of EDE scores here), 
which indicate low, moderate, and high levels of eating disorder symptoms (see Figure 2).  
The trajectories are almost perfectly parallel, demonstrating that the severity of problematic 
eating disorder attitudes and cognitions at pre-treatment has no impact on the amount of 
change in BMI during the early phase of treatment. 
Predictor 3: Pre-treatment BMI 
Running head: ANOREXIA SEVERITY AND DURATION IN CBT-E                          8 
 
 The slope of change in BMI over the course of treatment was associated with pre-
treatment BMI scores (p < .001).  However, this was because participants with low BMI 
values experienced larger improvements in BMI than participants with relatively high pre-
treatment BMIs (see top panel, Figure 3, for predicted trajectories for participants with BMIs 
of 15, 16, 17 and 18).  Pre-treatment BMI did not predict any other outcomes.  Figure 3 
(bottom panel) illustrates the lack of a relationship between pre-treatment BMI and changes 
in quality of life.  The slope of the trajectory was virtually identical for all levels of BMI. 
&RPSDULVRQZLWKH[LVWLQJSURSRVHGµFXW-RIIV¶IRU6(-AN 
To compare directly with previous findings (Calugi et al., 2016), we re-ran analyses 
after dichotomising illness duration into <7 years and >= 7 year categories.  Patients with 
illness duration >= 7 years had no worse outcome on any variable.  The µ! -\HDUGXUDWLRQ¶ 
threshold as a predictor of treatment completion performed extremely poorly in a Receiver 
Operating Characteristic analysis.  The sensitivity value (true positive rate) was 32%, 
specificity 51%, and overall accuracy 41% - worse than flipping a coin.  Similarly, we reran 
our analyses dichotomising patients based on pre-treatment BMI bands, with BMI < 16 
GHILQHGDVµVHYHUH¶(DSM-5; APA, 2013) DQG%0,DVµQRQ-VHYHUH¶7KHRQO\
relationship between severity and outcome was that patients with µVHYHUH¶%0,at pre-
treatment experienced significantly larger improvements in BMI over CBT-E (Figure 4). 
Discussion 
The present study examined whether AN duration or severity are associated with 
decreased likelihood of completing CBT-E or poorer treatment response.  We found only two 
associations between duration/severity and treatment outcome - both at odds with the 
assumption that greater duration or severity is associated with poorer treatment outcomes 
(e.g., patients with low BMIs at pre-treatment experienced greater improvements in BMI 
than those with high pre-treatment BMIs).  The consistent lack of associations across many 
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outcomes and three predictor variables strongly suggests that AN duration and severity are 
not predictive of poor outcome in CBT-E, and that nosologies that classify SE-AN by 
dichotomising illness duration or BMI may be of questionable validity and clinical utility.   
The status and meaning of µVHYHUHDQGHQGXULQJ¶$1 
The present findings strengthen recent studies showing that illness duration does not 
impact on outcomes in CBT-E (Calugi et al., 2017) and extend this research by demonstrating 
the robustness of this finding when duration and severity are considered dimensionally.  There 
is currently no meaningful cluster of features that constitutes a µVHYHUHDQGHQGXULQJ¶ variant 
of AN (Wildes et al., 2017; Wonderlich et al., 2012). Consequently, clinicians run the risk of 
using the term more or less arbitrarily (Broomfield et al., 2017).  In the absence of a meaningful 
FRQVWUXFW RI µVHYHUH DQG HQGXULQJ¶ AN, it follows that treatment recommendations for AN 
should be the same, regardless of illness duration or severity.  Guidelines proposing different 
treatment approaches for µVHYHUHDQGHQGXULQJ¶ AN should not be implemented unless clinical 
researchers can demonstrate that it is a useful construct. 
Clinical Implications 
The present findings offer hope for individuals who present to routine clinical settings 
with relatively severe and long lasting AN illness.  Evidence-based CBT-E is no less 
effective or acceptable for these individuals.  This information can be conveyed to patients at 
the start of treatment to instil hope ± they have just as much chance of achieving a good 
outcome in CBT-E as any other patient.  In the present study, patients with very low weight 
(BMI < 16) achieved the greatest weight regain over CBT-E.  Thus, even low-weight patients 
can engage in and benefit from CBT-E, despite engagement requiring complex cognitive and 
behavioural processes (e.g., reasoning and insight), and the need for real-time monitoring of 
nutritional intake, thoughts and feelings every day for many months.  Removing these critical 
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components of evidence-based treatments on the basis of duration or severity has the 
potential to limit treatment gains for individuals who would benefit. 
TKHXVHRIWKHWHUPµVHYHUHDQGHQGXULQJ¶ has the potential to result in even greater 
stigma than is currently experienced by individuals with eating disorders (e.g., BEAT, 2016).  
It can be used as a justification for clinicians to avoid applying effective treatment, as 
demonstrated by the finding that individuals with enduring AN are more likely to be offered 
non evidence-supported treatments (Wonderlich et al., 2012).  If illness duration and severity 
make no difference to treatment outcomes in CBT-E, discussion should shift from alternative 
treatments for SE-AN to improving treatments for all individuals with AN. 
Research Implications 
Strengths of the present study include the large clinical sample, examining the impact 
of illness duration and severity on treatment retention and outcome as continuous variables, 
and examining several indicators of treatment response.  The present findings do not rule out 
WKHSRVVLELOLW\WKDWDOWHUQDWLYHGHILQLWLRQVRIµVHYHUHDQGHQGXULQJ¶PLJKWEHSURJQRVWLFDOO\
useful, and do not permit conclusions regarding the impact of AN severity or duration on 
longer-term outcomes for patients with AN, as only post-treatment data were available.  
Further research is needed to examine whether the present findings generalise to 
younger patients (< 16 years) or to other evidence-supported treatments for AN.  We assessed 
illness duration based on a detailed self-report questionnaire and clinical interview.  Previous 
studies have similarly relied on self-reported illness duration (e.g., Wildes et al., 2017).  
While there is mixed evidence regarding the reliability of retrospective accounts (Solhan et 
al., 2009; Wonderlich et al., 2015), this limitation applies equally to the literature that has 
advocated the SE-AN categorisation.  Further research is needed to determine whether illness 
duration can be measured reliably using retrospective self-report, when the recall period 
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spans many years.  If not, this may further undermine the utility of classifying an individual 
based on illness duration until a more reliable measure can be established.   
Finally, it is possible that there may be associations between illness duration or 
severity that we did not have sufficient statistical power to detect in the present study.  
However, it is unlikely that any clinically significant effects have been missed because our 
sample size was large, and most outcomes were measured repeatedly during treatment, with 
all available values included in our regression models, which helps to substantially boost 
statistical power. The shape of predicted treatment trajectories (which were usually parallel), 
size of regression coefficients for interactions (which were often close to zero), and 
magnitude of p-values (which frequently approached 1) also suggest the reason we did not 
detect associations is because they do not exist or are so small as to be clinically meaningless. 
Conclusion 
The present findings are consistent with the conclusion of Wildes et al. (2017) that the 
µVHYHUHDQGHQGXULQJ¶$1FRQVWUXFWlacks predictive validity in terms of response to CBT-E.  
Individuals with the most severe and long-lasting AN symptoms did just as well in outpatient 
CBT-E as any other patient.  These findings offer hope for individuals affected by AN, and 
are a timely reminder to clinicians to administer evidence-supported treatments such as CBT-
E, regardless of duration or severity of illness.  
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Footnotes 
1
 This is also referred to in the literature as covariance pattern modelling, mixed-effect 
repeated measures (MMRM), or generalised least square (GLS). 
2
 Mean EDE-Q Global for Australia community sample is 1.52 (SD = 1.25; Mond et 
al., 2004)
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Table 1 
Pre-Treatment Demographic Characteristics 
Characteristic %  
Age (years) 22 [18, 25] 
Female 97.0 
Australian born 76.9 
Employed 56.0 
Relationship Status  
Single 74.6 
Married / Defacto 20.2 
Other 5.2 
Highest Level of Education Completed  
Less than Year 12 30.9 
Year 12 37.4 
Trade / Technical 8.1 
Tertiary 23.6 
Prior History of Psychological 
Treatment 91.8 
History of Psychiatric Hospitalization 55.2 
Attempted Suicide 24.6 
Engaged in Other Self Harm 44.0 
Taking Psychiatric Medication 47.1 
Illness Duration (years) 5 [3, 12] 
Body Mass Index (BMI) 16.8 (1.5) 
EDE Global Score 3.7 (1.3) 
EDE-Q Global Score 3.9 (1.4) 
QLESQ 45.7 (18.7) 
 
Note.  The median and interquartile range (lower quartile, upper quartile) have been reported 
for age and illness duration as those variables were skewed.  Means and standard deviations 
are reported for BMI, EDE, EDEQ and QLESQ.  All other numbers represent percentages.  
EDE = Eating Disorders Examination.  EDE-Q = Eating Disorder Examination 
Questionnaire.  QLESQ = Quality of Life Enjoyment and Satisfaction Scale ± Short Form. 
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Figure 1. Relationships between duration of Anorexia Nervosa and treatment outcome 
a) Association Between Duration and Treatment Completion 
 
b) Association Between Duration and Change in Eating Disorder Symptoms 
 
Note. In upper panel, the shaded area represents 95% confidence band. 
Running head: ANOREXIA SEVERITY AND DURATION IN CBT-E                          19 
 
Figure 2. Relationship between eating disorder symptom severity, as measured by the Eating 
Disorder Examination (EDE) global score, and change in body mass index (BMI) during the 
first five sessions of treatment. 
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Figure 3. Relationships between severity of symptoms, as measured by pre-treatment Body 
Mass Index (BMI), and treatment outcome 
a) Association Between Pre-treatment BMI and Change in BMI During Treatment 
 
b) Association Between Pre-treatment BMI and Quality of Life 
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Figure 4. Relationship between Severe and Enduring Anorexia Nervosa (SE-AN) and change 
in Body Mass Index (BMI) during treatment.  Participants with a BMI at pre-treatment < 16 
were classified as having SE-AN; those with BMIs  16 were classified as not having SE-AN. 
 
Note. The shaded areas represent 95% confidence bands. 
 
